Article Sidebar

PDF (Tiếng Việt)
Published: 2026-08-04
Abstract Views: 0
Views PDF (Tiếng Việt): 0
DOI: https://doi.org/10.52852/tcncyh.v204i7.5266
Issue
Vol. 204 No. 7 (2026)
Section
Các bài báo
How to Cite
Hạnh, C. V. N., Phương, P. C., Nam, L. V., Huệ, Đoàn T., & An, T. T. H. (2026). Characteristics of sleep disturbances in patients with non-small cell lung cancer at Bach Mai hospital. Journal of Medical Research, 204(7), 213-221. https://doi.org/10.52852/tcncyh.v204i7.5266

Characteristics of sleep disturbances in patients with non-small cell lung cancer at Bach Mai hospital

Chu Vu Nguyen Hanh, Pham Cam Phuong, Le Viet Nam, Doan Thi Hue, Tran Thi Ha An

Main Article Content

Abstract

This study aimed to describe the characteristics of sleep disorders among patients with non-small cell lung cancer (NSCLC) at Bach Mai Hospital, using a cross-sectional descriptive design. The study was conducted on 184 inpatients treated from September 2025 to March 2026. The results showed that 61.41% of patients experienced sleep disorders. Insomnia was the most common (58.15%), followed by obstructive sleep apnea, restless legs syndrome, circadian rhythm sleep-wake disorders, and nightmares. The mean Pittsburgh Sleep Quality Index (PSQI) score was 9.52 ± 4.57, with 72.28% of patients having poor sleep quality (PSQI > 5). According to the Insomnia Severity Index (ISI), the prevalence of insomnia was 53.80%, with a mean score of 8.27 ± 6.51. Common manifestations of sleep disorders included difficulty initiating sleep, difficulty maintaining sleep, nocturnal awakenings, and reduced sleep efficiency. The study recommends that sleep screening and assessment be integrated into routine clinical practice to enable early identification and timely intervention of sleep disorders, thereby contributing to improved quality of life and treatment outcomes in patients.

Article Details

Keywords

Sleep disturbances; non-small cell lung cancer

References

1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3): 229-263. doi:10.3322/caac.21834.
2. Hu Y, Xiao LD, Tang C, Cao W, Wang Y. Prevalence and risk factors of sleep disturbances among patients with lung cancer: systematic review and meta-analysis. Support Care Cancer. 2024; 32(9): 619. doi:10.1007/s00520-024-08798-4.
3. Pigeon WR, Pinquart M, Conner K. Meta-Analysis of Sleep Disturbance and Suicidal Thoughts and Behaviors. J Clin Psychiatry. 2012; 73(09): e1160-e1167. doi:10.4088/JCP.11r07586.
4. Li N, Xue D, Zhao X, et al. Sleep disturbance as a poor prognostic predictor in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A prospective study. J Psychosom Res. 2024; 186: 111892. doi:10.1016/j.jpsychores.2024.111892.
5. American Psychiatric Association, American Psychiatric Association, eds. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. American Psychiatric Association; 2013.
6. Chu Thị Hoài, Hồ Thị Minh Thu, Hoàng Thị Thanh Hoài, Lê Thị Diệu Linh. Chất lượng giấc ngủ và một số yếu tố liên quan ở bệnh nhân ung thư phổi tại Bệnh viện Ung bướu Nghệ An năm 2023. Tạp chí Y học Việt Nam. 2024; 538(1). doi:10.51298/vmj.v538i1.9332.
7. Nguyen KT, Pham TH, Ngo VL, et al. Lung Cancer Outcomes in Vietnam: A 6-Year Retrospective Study. J Immunother Precis Oncol. 2025; 8(4): 254-262. doi:10.36401/JIPO-25-12.
8. National Cancer Institute. Cancer of the lung and bronchus - cancer stat facts. Surveillance, Epidemiology, and End Results Program. Accessed April 21, 2026. https://seer.cancer.gov/statfacts/html/lungb.html.
9. Martin RE, Loomis DM, Dean GE. Sleep and quality of life in lung cancer patients and survivors. J Am Assoc Nurse Pract. 2021; 34(2): 284-291. doi:10.1097/JXX.0000000000000625.
10. Al Maqbali M, Al Sinani M, Alsayed A, Gleason AM. Prevalence of Sleep Disturbance in Patients With Cancer: A Systematic Review and Meta-Analysis. Clin Nurs Res. 2022; 31(6): 1107-1123. doi:10.1177/10547738221092146.
11. Pham AT, Do MT, Tran HTT. A cross-sectional study of sleep disturbance among middle-aged cancer patients at Vietnam National Cancer Hospital. Cancer Rep. 2024; 7(4): e2055. doi:10.1002/cnr2.2055.
12. Pérez-Warnisher MT, Cabezas E, Troncoso MF, et al. Sleep disordered breathing and nocturnal hypoxemia are very prevalent in a lung cancer screening population and may condition lung cancer screening findings: results of the prospective Sleep Apnea In Lung Cancer Screening (SAILS) study. Sleep Med. 2019; 54: 181-186. doi:10.1016/j.sleep.2018.10.020.
13. Liu W, Zhou L, Zhao D, et al. Development and Validation of a Prognostic Nomogram in Lung Cancer With Obstructive Sleep Apnea Syndrome. Front Med. 2022; 9: 810907. doi:10.3389/fmed.2022.810907.
14. Saini A, Berruti A, Ferini-Strambi L, et al. Restless legs syndrome as a cause of sleep disturbances in cancer patients receiving chemotherapy. J Pain Symptom Manage. 2013; 46(1): 56-64. doi:10.1016/j.jpainsymman.2012.06.018.
15. Hoang HTX, Molassiotis A, Chan CW, Nguyen TH, Liep Nguyen V. New-onset insomnia among cancer patients undergoing chemotherapy: prevalence, risk factors, and its correlation with other symptoms. Sleep Breath. 2020; 24(1): 241-251. doi:10.1007/s11325-019-01839-x.